Gene · 3191
Papers1,883
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,883
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | EMBO Rep | 2022 | 35785414 | PubTator, text mining | PubMed |
| Viral Circular RNAs and Their Possible Roles in Virus-Host Interaction. | Front Immunol | 2022 | 35784275 | PubTator, text mining | PubMed |
| Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | Life Sci Alliance | 2022 | 35777956 | PubTator, text mining | PubMed |
| Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. | J Exp Clin Cancer Res | 2022 | 35773731 | PubTator, text mining | PubMed |
| circRNA: Regulatory factors and potential therapeutic targets in inflammatory dermatoses. | J Cell Mol Med | 2022 | 35770323 | PubTator, text mining | PubMed |
| The Isolation and Full-Length Transcriptome Sequencing of a Novel Nidovirus and Response of Its Infection in Japanese Flounder (Paralichthys olivaceus). | Viruses | 2022 | 35746687 | PubTator, text mining | PubMed |
| The Role of Epigenetic in Dental and Oral Regenerative Medicine by Different Types of Dental Stem Cells: A Comprehensive Overview. | Stem Cells Int | 2022 | 35721599 | PubTator, text mining | PubMed |
| Implementing a preimplantation proteomic approach to advance assisted reproduction technologies in the framework of predictive, preventive, and personalized medicine. | EPMA J | 2022 | 35719135 | PubTator, text mining | PubMed |
| Body temperature variation controls pre-mRNA processing and transcription of antiviral genes and SARS-CoV-2 replication. | Nucleic Acids Res | 2022 | 35713540 | PubTator, text mining | PubMed |
| Identification of Core Genes and Screening of Potential Targets in Intervertebral Disc Degeneration Using Integrated Bioinformatics Analysis. | Front Genet | 2022 | 35711934 | PubTator, text mining | PubMed |
| Identification of Crucial lncRNAs for Luminal A Breast Cancer through RNA Sequencing. | Int J Endocrinol | 2022 | 35692369 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Using Next-Generation Sequencing and Bioinformatic Methods to Predict New Genes That May Be Regulated by CD47 in Oral Squamous Cell Carcinoma. | Curr Issues Mol Biol | 2022 | 35678681 | PubTator, text mining | PubMed |
| RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition. | Nat Commun | 2022 | 35676246 | PubTator, text mining | PubMed |
| AKT constitutes a signal-promoted alternative exon-junction complex that regulates nonsense-mediated mRNA decay. | Mol Cell | 2022 | 35675814 | PubTator, text mining | PubMed |
| SETD2: from chromatin modifier to multipronged regulator of the genome and beyond. | Cell Mol Life Sci | 2022 | 35661267 | PubTator, text mining | PubMed |
| CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. | J Exp Clin Cancer Res | 2022 | 35655258 | PubTator, text mining | PubMed |
| Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. | J Control Release | 2022 | 35649485 | PubTator, text mining | PubMed |
| Exosome-Associated circRNAs as Key Regulators of EMT in Cancer. | Cells | 2022 | 35626752 | PubTator, text mining | PubMed |
| Intracellular Protein S-Nitrosylation-A Cells Response to Extracellular S100B and RAGE Receptor. | Biomolecules | 2022 | 35625541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3191/papers?page=21